Abbott Laboratories (rights to Gabitril) Overview
- Founded
-
1998
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Abbott Laboratories (rights to Gabitril) General Information
Description
A drug manufacturing rights. The drug is a treatment for partial seizures related to epilepsy enabling patience in reducing the frequency of partial seizures when added to an existing regimen of at least one other antiepilepsy drug.
Contact Information
Website
www.gabitril.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Chicago, IL
- United States
Abbott Laboratories (rights to Gabitril) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Abbott Laboratories (rights to Gabitril) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|